Early stage funding rounds accounted for 75.6% of total investment volume during Q2 2019, says GlobalData

Early stage funding rounds (comprising Seed and Series A funding rounds) accounted for 75.6% of total investment volume during the second quarter (Q2) of 2019, according to GlobalData, a leading data and analytics company.

On the other hand, late stage funding rounds such as Series H, Series I and Series J were almost non-existent in Q2 2019.

The US and China collectively accounted for more than 60% of early stage funding and more than 70% of growth/expansion/late stage funding (comprising Series B, Series C, Series D, Series E, Series F, Series G, Series H, Series I and Series J) volume in Q2 2019.

Other key countries that attracted a significant number of early stage funding during the period include India, the UK, Canada, Singapore, Israel, Australia, Germany, Switzerland, France, Indonesia, Spain and the UAE.

April 2019 registered 1,006 deals with disclosed funding rounds, out of which early stage funding rounds accounted for 75.6% share. The US topped the list  by attracting 45.7% of early stage funding volume. China held the second position with 18.4% share of early stage funding volume during the month.

India, the UK, Singapore, Canada, Switzerland, Australia, the UAE and Israel were among the other key countries that attracted a significant number of early stage funding during April.

Some of the notable early stage funding rounds announced during the month include US$298.3m Series A funding raised by China-based ENOVATE, US$200m Series A funding in Singapore-based Blockchain Exchange Alliance, and US$100m Series A funding raised by the US-based Talaris Therapeutics.

In May 2019, venture capital (VC) investments with disclosed funding rounds witnessed a decline of 6.1% compared to the previous month due to a decrease in the number of Series A, Series B, Series C and Series D funding rounds from 547 in April to 468 in May.

In contrast, seed funding rounds witnessed growth in volume and share from 44.7% in April to 48.4% in May. In fact, the month registered the highest number of seed funding rounds in Q2 2019.

While May was also the only month in Q2 2019 to witness Series I and Series J funding rounds, it did not register any Series H funding round.

The US garnered the highest number of early stage funding rounds with 47.8% share, distantly followed by China with 15.6% share. Other top countries that attracted a significant number of early stage funding during the month include the UK, India, Singapore, Canada, Germany, Australia, Israel and Indonesia.

Some of the notable early stage funding rounds announced during May include US$1bn Series A funding in Chinese firm JD Health, US$230m Series A funding raised by the UK-based Checkout.com and US$150m Series A funding raised by the US-based ElevateBio.

In June 2019, VC investments with disclosed funding rounds declined by 18.6% as compared to the previous month due to low seed funding volume. On the other hand, the share of VC funding deals across most of the other funding rounds witnessed growth.

While June was the only month in Q2 2019 to record Series H funding round, it did not record any Series I and Series J funding round.

The US accounted for 44.3% of early stage funding volume followed by China with 19.5% share during the month. The UK, India, Canada, Germany, Israel, France, Spain and Australia were among the other key countries that attracted a significant number of early stage funding during June.

Some of the notable early stage funding rounds announced during the month include US$115m Series A funding raised by the US-based Commonwealth Fusion Systems, US$92.2m Series A funding raised by China-based Dailuobo and US$67m raised by the US-based Frontier Medicines.

More Media